AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 19 filers reported holding AZURRX BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $57,000 | -38.7% | 69,835 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $93,000 | +38.8% | 69,835 | 0.0% | 0.01% | +20.0% |
| Q4 2020 | $67,000 | +36.7% | 69,835 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $49,000 | -22.2% | 69,835 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $63,000 | +57.5% | 69,835 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $40,000 | -44.4% | 69,835 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $72,000 | +75.6% | 69,835 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $41,000 | -65.3% | 69,835 | 0.0% | 0.00% | -69.2% |
| Q2 2019 | $118,000 | -30.2% | 69,835 | 0.0% | 0.01% | -31.6% |
| Q1 2019 | $169,000 | – | 69,835 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARSONS CAPITAL MANAGEMENT INC/RI | 434,783 | $1,117,000 | 0.12% |
| J. Goldman & Co LP | 425,358 | $1,093,000 | 0.08% |
| 683 Capital Management, LLC | 400,000 | $1,028,000 | 0.07% |
| ARDSLEY ADVISORY PARTNERS LP | 150,000 | $386,000 | 0.05% |
| GILDER GAGNON HOWE & CO LLC | 556,537 | $1,430,000 | 0.02% |
| TIEDEMANN ADVISORS, LLC | 60,000 | $154,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 131,456 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,780 | $59,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $1,285,000 | 0.00% |
| Rockefeller Capital Management L.P. | 16,971 | $44,000 | 0.00% |